DAVIS TODD C purchased 6.3% of their position (9.51K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market purchase worth $1.00M — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 5/13/2025ACC: 0002001011-25-000029
+9.51K
Net shares
Net buyer
$1.00M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
9.51K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+1.68K
Price / share
$104.57
Trade value
$175.68K
% of position
1.1%
5/9/2025
151.72K→153.40K
Common Stock
Direct
Shares
+2.31K
Price / share
$104.53
Trade value
$241.15K
% of position
1.5%
5/9/2025
153.40K→155.71K
Common Stock
Direct
Shares
+5.52K
Price / share
$105.67
Trade value
$583.63K
% of position
3.5%
5/9/2025
155.71K→161.23K
Total
Net shares
+9.51K
Net value
$1M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/9/2025 | P · Purchase | +1.68K | $104.57 | $175.68K | 1.1% | 151.72K | 153.40K |
| Common Stock Direct | 5/9/2025 | P · Purchase | +2.31K | $104.53 | $241.15K | 1.5% | 153.40K | 155.71K |
| Common Stock Direct | 5/9/2025 | P · Purchase | +5.52K | $105.67 | $583.63K | 3.5% | 155.71K | 161.23K |
| Total | +9.51K | $1M | ||||||
Derivative Transactions0
No derivative transactions reported